Niranjan Kumar: Email & Phone Number

Work Experience 37 years

Chief Executive Officer & President at ABSINCGROUP

Jan 2020 - Current

Managing Director at ABSINCGROUP

Jan 2020 - Dec 2025

Board of Director at Genomic Diagnostics USA

Aug 2019 - Current

Chief Executive Officer at sAAVient Therapeutics

Aug 2025 - May 2026

CEO and President at American BioSources Inc

Jul 2010 - Jun 2019

Senior Regulatory Expert Consultant -Vaccines at Gates Foundation

Jan 2012 - Dec 2012

Senior Vice President at Wockhardt Ltd.

Jan 2008 - Dec 2009

Executive Director -Biologics & Vaccines at Novavax

Jan 2006 - Dec 2007

Dy. Director - Biologics & Vaccines at Sanofi

Jan 2001 - Jan 2006

Dy. Director - Conjugated, Bacterial & Viral Vaccines at Sanofi

Jan 2001 - Jan 2006

Senior Scientist/Group Leader - Prevnar & Other Vaccines at Pfizer

Jan 1998 - Jan 2000

Senior Scientist -MMRV VACCINES at Merck

Jan 1996 - Jan 1998

Assistant Professor of Medicine Molecular & Cell Biology &Biochemistry at University at Buffalo

Jan 1990 - Dec 1997

Postdoctoral Scientist at University of Rochester Medicine

Jan 1989 - Dec 1990

Niranjan is proficient in English, French, and Hindi. Their professional focus is 21 CFR Part 11, Artificial Intelligence (AI), and Assay Development across 3 core areas.

Niranjan holds WHO IS WHO, Lean Six Sigma Black Belt CERTIFIED, and Certificate of Supply Chain Management and Logistics certifications and has registered patents, including "Synergistic Cannabinoid Compositions with Hormonal Modulation, Enhanced Stability, and Probiotic Support for Neuroendocrine and Metabolic Health, Plant-Protective Antimicrobial Composition and Method for Disease Suppression in Fruits, Vegetables, and Ornamental Plants, and NON-PPHARMACEUTICAL AND THERAPEUTIC PREPARATIONS TO IMPROVE ORAL HYGIENE AND BRAIN HEALTH". They have also been awarded Lean Six Sigma Black Belt